Cargando…

Effectiveness of Transcranial Direct Current Stimulation in Chronic Daily Headaches: An Experimental Single Case Report with a Novel Protocol

Chronic daily headaches are often refractory to prescribed or non-prescribed medications. Transcranial direct current stimulation (tDCS) is a new technological-based intervention with various modes of applicability. Therefore, we aimed to study the effectiveness of tDCS in an individual with symptom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rahimi, Mohammad Dawood, Zargani, Hedieh, Nikkhah, Karim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2022
Materias:	Single Case − Headache
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941777/ https://www.ncbi.nlm.nih.gov/pubmed/36824576 http://dx.doi.org/10.1159/000527021

Ejemplares similares

Headaches and obesity
por: Fortini, Ida, et al.
Publicado: (2022)

Headache as an acute and post‐COVID‐19 symptom in COVID‐19 survivors: A meta‐analysis of the current literature
por: Fernández‐de‐las‐Peñas, César, et al.
Publicado: (2021)

Successful Treatment of Airplane Headache with Rizatriptan: Case Report
por: Delva, Iryna, et al.
Publicado: (2021)

Cluster-Like Headache Revealing Polycythemia Vera: A Case Report
por: Popescu, Cyprian
Publicado: (2020)

Neurosarcoidosis Presenting as Young-Onset Chronic Headache: A Case Report
por: Ray, Barun Kumar, et al.
Publicado: (2021)

Headache due to Bilateral Subacute Subdural Hematomas following Intracranial Hypotension Caused by Cervical Disc Herniation
por: Steenstraten, Iris, et al.
Publicado: (2021)

Chronic daily headache in a paediatric headache centre
por: Scalas, C., et al.
Publicado: (2005)

Multinational descriptive analysis of the real‐world burden of headache using the Migraine Buddy application
por: Goadsby, Peter J., et al.
Publicado: (2021)

Post Stroke Mirror Movements Preventing Performance of Bilateral Movements and Activities of Daily Living
por: Suzuki, Hokuto, et al.
Publicado: (2022)

Behavioural intervention in medication overuse headache: A concealed double‐blind randomized controlled trial
por: Pijpers, Judith A., et al.
Publicado: (2022)

Headache advocacy
por: Grisold, Wolfgang, et al.
Publicado: (2023)

When cluster headache was called histaminic cephalalgia (Horton’s headache)
por: Fanciullacci, M.
Publicado: (2006)

Noninvasive vagus nerve stimulation and morphine transiently inhibit trigeminal pain signaling in a chronic headache model
por: Cornelison, Lauren E., et al.
Publicado: (2020)

Blunt Head Trauma and Headache
por: Chelse, Ana B., et al.
Publicado: (2015)

Medication–overuse headache: pathophysiological insights
por: Calabresi, P., et al.
Publicado: (2005)

Improved Osteoarthritis during Erenumab Treatment for Migraine: A Case Report
por: Jantzen, Frederik Thal, et al.
Publicado: (2023)

Neurophysiological approach to central pain modulation in primary headaches
por: Rossi, P., et al.
Publicado: (2005)

A Case of HaNDL with Low Cerebrospinal Fluid Level of Neurofilament Light Chain
por: Sisman, Aysel Büsra, et al.
Publicado: (2020)

Reversible Cerebral Vasoconstriction Syndrome after Nifedipine Withdrawal
por: Alanazy, Mohammed H., et al.
Publicado: (2020)

R1352Q CACNA1A Variant in a Patient with Sporadic Hemiplegic Migraine, Ataxia, Seizures and Cerebral Oedema: A Case Report
por: Stubberud, Anker, et al.
Publicado: (2021)

Adult Abdominal Migraine Improved by OnabotulinumtoxinA Injections
por: Hermanowicz, Neal
Publicado: (2021)

Atypical Perfusion Manifestation in Migraine with Aura
por: Lester, Jacobo, et al.
Publicado: (2021)

Severe acute respiratory syndrome coronavirus 2 infection altered the factors associated with headache: evidence from a multicenter community-based case–control study
por: Ali, Mohammad
Publicado: (2022)

Acute Migraine Therapy: New Drugs and New Approaches
por: Monteith, Teshamae S., et al.
Publicado: (2010)

Cold extremities in migraine: a marker for vascular dysfunction in women
por: Linstra, K. M., et al.
Publicado: (2020)

Chronic migraine: Genetics or environment?
por: Chalmer, Mona Ameri, et al.
Publicado: (2021)

Long‐term efficacy and safety of erenumab in migraine prevention: Results from a 5‐year, open‐label treatment phase of a randomized clinical trial
por: Ashina, Messoud, et al.
Publicado: (2021)

Why are CGRP monoclonal antibodies not yet the first line treatment in migraine prevention?
por: Simioni, Caio Vinicius de Meira Grava
Publicado: (2022)

Update on Idiopathic Intracranial Hypertension Management
por: Souza, Marcio Nattan Portes, et al.
Publicado: (2022)

Vestibular migraine
por: Silva, Viviane Passarelli Ramin, et al.
Publicado: (2022)

It is time anti-CGRP monoclonal antibodies be considered first-line prophylaxis for migraine
por: Kubota, Gabriel Taricani
Publicado: (2022)

Erenumab in chronic migraine: Experience from a UK tertiary centre and comparison with other real‐world evidence
por: Khalil, Modar, et al.
Publicado: (2022)

Treatment with the monoclonal calcitonin gene‐related peptide receptor antibody erenumab: A real‐life study
por: de Vries Lentsch, Simone, et al.
Publicado: (2021)

First‐line steroid treatment for spontaneous intracranial hypotension
por: Tonello, Simone, et al.
Publicado: (2022)

Clinic and genetic predictors in response to erenumab
por: Zecca, Chiara, et al.
Publicado: (2022)

Functional connectivity changes in complex migraine aura: beyond the visual network
por: Silvestro, Marcello, et al.
Publicado: (2021)

Maintenance of response and predictive factors of 1‐year GalcanezumAb treatment in real‐life migraine patients in Italy: The multicenter prospective cohort GARLIT study
por: Vernieri, Fabrizio, et al.
Publicado: (2022)

Attachment styles and headache
por: Savi, L., et al.
Publicado: (2005)

Headache and botulinum toxin
por: Porta, M., et al.
Publicado: (2005)

Headache and mood disorders
por: De Filippis, S., et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_24i8r2oa35cqouobgfge9t8ubm